(Q28165540)
Statements
Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET) (English)
0 references
1 October 2003
0 references
42
0 references
7
0 references
1188-95
0 references